Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
other: read across from analogue substance
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: The study has been presented to ECHA in the framework of a NONS notification. The document is now public because presented more than 12 years ago. The summary received is from migrated NONS dossier

Data source

Reference
Reference Type:
other: Body responsible for the test
Title:
Unnamed
Year:
1991

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
GLP compliance:
yes
Type of assay:
chromosome aberration assay

Test material

Constituent 1
Reference substance name:
Direct Blue 267
IUPAC Name:
Direct Blue 267

Test animals

Species:
mouse
Strain:
NMRI

Administration / exposure

Route of administration:
oral: unspecified
Vehicle:
distilled water
No. of animals per sex per dose:
15 males at 400 mg/kg sacrificed at 24, 48 an 72h ( 5 males at each time point)15 females at 400 mg/kg sacrificed at 24, 48 and 72h (5 females at each time point)

Results and discussion

Test results
Sex:
not specified
Genotoxicity:
negative
Remarks:
P/N ratio not significantly changed
Toxicity:
yes
Additional information on results:
No apparent citotoxicity effect: PCE/NCE ratio

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): negativeThe substance was tested for in vivo genotixicity following in vivo test OECD 474. Under the experimental conditions the P/N is not significantly changed.
Executive summary:

The substance was tested for in vivo genotixicity following in vivo test OECD 474. Mice were orally dosed at 400 mg/kg (maximum tolerated dose) and sacrified at 24, 48 and 72h. No apparent citotoxicity was observed and the P/N was not significantly changed.